Calcipotriol: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| (9 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
<StructureSection load='' size='340' side='right' caption='Caption for this structure' scene=''> | <StructureSection load='' size='340' side='right' caption='Caption for this structure' scene='10/1023614/Cv/1'> | ||
Calcipotriol, also known as calcipotriene, is a synthetic derivative of calcitriol, a form of [[Secosteroids|vitamin D]]. It is used in the treatment of psoriasis. It is safe for long-term application in psoriatic skin conditions. See also [https://en.wikipedia.org/wiki/Calcipotriol]. | Calcipotriol, also known as calcipotriene, is a synthetic derivative of [[calcitriol]], a form of [[Secosteroids|vitamin D]]. It is used in the treatment of psoriasis. It is safe for long-term application in psoriatic skin conditions. See also [https://en.wikipedia.org/wiki/Calcipotriol Calcipotriol] and [[Vitamin D receptor]] (also called calcitriol receptor). | ||
The precise mechanism of calcipotriol in remitting psoriasis is not well understood. However, it has been shown to have comparable affinity with calcitriol for the [[vitamin D receptor]] (VDR), while being less than 1% as active as the calcitriol in regulating calcium metabolism. The vitamin D receptor belongs to the steroid/thyroid receptor superfamily, and is found on the cells of many different tissues including the thyroid, bone, kidney, and T cells of the immune system. T cells are known to play a role in psoriasis, and it is thought that the binding of calcipotriol to the VDR modulates the T cells gene transcription of cell differentiation and proliferation related genes. | |||
In mouse studies, topical calcipotriol administration to the ear and dorsal skin led to a dose-dependent increase in the production of the epithelial cell-derived cytokine TSLP by keratinocytes, and triggered atopic dermatitis at high concentrations.<ref name="a10">PMID:16880407</ref> This upregulation of TSLP production due to calcipotriol application is thought to be mediated through the coactivation of [[vitamin D receptor]]/[[Retinoid X receptor]] α and [[vitamin D receptor]]/[[Retinoid X receptor]] β heterodimers. | |||
[[1s19]]. | <scene name='10/1023614/Cv/2'>VDR ligand binding domain complexed to calcipotriol</scene> ([[1s19]]). | ||
<scene name='10/1023614/Cv/3'>Calcipotriol binding site</scene>. | |||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Latest revision as of 07:46, 23 January 2024
| ||||||||||||